Shannon Cornett, PhD, Bruker Daltonics Imaging Business Manager, & Erin Seeley, PhD, New River Labs Chief Technology Officer
Location: TBRC C2195
The Center for Biomedical Mass Spectrometry Research invites basic science, clinical and translational researchers and staff to attend a special seminar at 4:00 pm, Thursday, September 20th, in TBRC 2195. Dr. Shannon Cornett, Imaging Business Manager for Bruker Daltonics, will discuss how MALDI Imaging technology serves as a label-free molecular imaging method to help understand the molecular pathology of tissue. Dr. Erin Seeley, Chief Technology Officer for New River Labs, will discuss how Mass Spectrometry Imaging bridges the gap between histology and molecular biology.
Dr. Cornett spent eight years at Bruker developing applications and platforms for MALDI TOF, before joining Vanderbilt University as an Assistant Professor of Biochemistry in 2002. He worked with Professor Richard Caprioli developing tools and methodologies in imaging mass spectrometry. Dr. Cornett now manages Bruker’s MS imaging business.
Dr. Seeley received a PhD from Purdue in Analytical Chemistry with a focus in Phosphoproteomics. She spent several years working under the direction of Richard Caprioli in the Tissue Imaging Core at Vanderbilt University. Dr. Seeley moved to Protea Biosciences in 2014, managing MALDI imaging service work relating to clinical applications and small molecule quantitation. She co-founded New River Labs this year, which helps develop mass spectrometry imaging-based diagnostic and prognostic assays.
Refreshments will be provided.